Compounds > platinum
Page last updated: 2024-08-22

platinum and Pleural Effusion, Malignant

platinum has been researched along with Pleural Effusion, Malignant in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's4 (36.36)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Davidson, B; Elstrand, MB1
Fang, C; Fu, Z; Jiang, H; Li, J; Lu, Q; Pei, Z; Wang, E; Wang, H; Wang, J; Wang, S1
Li, Q; Li, YQ; Liang, R; Lin, Y; Liu, ZH; Xie, HY; Yuan, CL1
Ishida, H; Kaneko, K; Kobayashi, K; Nitanda, H; Sakaguchi, H; Yamazaki, N1
Choi, JH; Choi, YW; Han, JH; Hwang, SC; Jeong, SH; Jung, JH; Kang, SY; Kim, JH; Lee, HW; Oh, YT; Park, KJ; Sheen, SS1
Dodič-Fikfak, M; Dolžan, V; Erčulj, N; Franko, A; Hmeljak, J; Kovač, V1
Abu-Rustum, N; Barakat, RR; Chi, DS; Eitan, R; Franklin, CC; Huh, JN; Levine, DA; Sonoda, Y; Stevens, TA1
Bogliolo, G; Bottino, GB; Esposito, M; Lerza, R; Pannacciulli, I; Vannozzi, M1
Hirose, N; Nagashima, A; Nakahashi, H; Shimokawa, T; Yasumoto, K1
Asoh, H; Fukuyama, Y; Ichinose, Y; Kuninaka, S; Miyagi, J; Terazaki, Y; Yano, T; Yokoyama, H1
Arimoto, T; Fujii, T; Fujita, Y; Gotoh, T; Hiramori, N; Iwasaki, Y; Kida, T; Nakagawa, M; Nakamura, T; Sakai, M1

Reviews

1 review(s) available for platinum and Pleural Effusion, Malignant

ArticleYear
Intraperitoneal Perfusion Therapy of Endostar Combined with Platinum Chemotherapy for Malignant Serous Effusions: A Meta-analysis.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Endostatins; Humans; Infusions, Parenteral; Perfusion; Platinum; Pleural Effusion, Malignant; Prognosis; Randomized Controlled Trials as Topic

2015

Other Studies

10 other study(ies) available for platinum and Pleural Effusion, Malignant

ArticleYear
Clinicopathological prognostic parameters in patients with tubo-ovarian carcinoma effusions.
    Cytopathology : official journal of the British Society for Clinical Cytology, 2022, Volume: 33, Issue:4

    Topics: Biomarkers, Tumor; Carcinoma; Cystadenocarcinoma, Serous; Female; Humans; Ovarian Neoplasms; Platinum; Pleural Effusion, Malignant; Prognosis; Retrospective Studies

2022
Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.
    Molecular medicine reports, 2015, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gene Expression; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; MyoD Protein; Myoglobin; Myosin Type II; Platinum; Pleural Effusion, Malignant; Prognosis; Ribonucleoside Diphosphate Reductase; Thymidylate Synthase; Tubulin; Tumor Suppressor Proteins

2015
Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
    Lung cancer (Amsterdam, Netherlands), 2017, Volume: 104

    Topics: Adult; Aged; Cisplatin; Female; Humans; Hyperthermia, Induced; Infusions, Intralesional; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Perfusion; Platinum; Pleural Cavity; Pleural Effusion, Malignant; Pleural Neoplasms; Prospective Studies; Thoracic Surgery, Video-Assisted

2017
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy.
    Lung cancer (Amsterdam, Netherlands), 2009, Volume: 65, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Pleural Effusion, Malignant; Prognosis; Proto-Oncogene Proteins c-bcl-2; Recurrence; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53

2009
DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cell Cycle Proteins; Deoxycytidine; DNA; DNA Repair; DNA-Binding Proteins; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Nuclear Proteins; Peritoneal Neoplasms; Platinum; Pleural Effusion, Malignant; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Prognosis; Rad51 Recombinase; Survival Rate; X-ray Repair Cross Complementing Protein 1

2012
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
    Cancer, 2005, Apr-01, Volume: 103, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Pleural Effusion, Malignant; Prognosis; Retrospective Studies; Survival Rate

2005
High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
    Cancer, 1994, Jan-01, Volume: 73, Issue:1

    Topics: Absorption; Cisplatin; Drug Administration Schedule; Drug Tolerance; Feasibility Studies; Humans; Injections; Male; Mesothelioma; Middle Aged; Platinum; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Remission Induction

1994
Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer.
    Journal of surgical oncology, 1993, Volume: 54, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Instillation, Drug; Lung Neoplasms; Male; Middle Aged; Platinum; Pleura; Pleural Effusion, Malignant; Pleurisy; Pneumonectomy; Prognosis

1993
Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis.
    Journal of surgical oncology, 1997, Volume: 66, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Hypotonic Solutions; Intraoperative Care; Lung Neoplasms; Male; Middle Aged; Platinum; Pleural Effusion, Malignant; Pleurisy; Retrospective Studies; Survival Rate; Thoracotomy

1997
[Evaluation of carboplatin administration into the serous cavity in the treatment of malignant effusion].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11

    Topics: Aged; Carboplatin; Drug Evaluation; Female; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Platinum; Pleural Effusion, Malignant

1991